Exclusive Scabies Webinar

A New Agent to Address the Most Common Parasitic Skin Disease

Dr. Ahmad Amin

with Dr. Ahmad Amin

Tuesday, October 18th at
6:00pm PST / 7:00pm MST

Food Voucher Icon

Special offer below!

About the Webinar

After 30 years without any advancement in scabies therapy, novel NatrobaTM is the first targeted topical agent to demonstrate what the FDA now defines as a “complete cure”.1

In this webinar, you’ll learn about the new FDA guidelines for efficacy and how the patented NatrobaTM (spinosad) formulation delivers unparalleled efficacy and safety in adult and pediatric patients based on two Phase III clinical trials.1-3

You’ll also have an opportunity to discuss this important new treatment option live with the clinical expert.

About the Speaker

Dr. Ahmad Amin is an Assistant Professor of Dermatology at Northwestern University Feinberg School of Medicine and physician at Northwestern Medicine Dermatology in Chicago, IL.

Reserve Your Place

Thanks for your interest!

Keep an eye on your inbox. We’ll send a reminder email the week of the webinar. In the meantime, learn more about Natroba™.

Food Voucher Icon

Attend this webinar, and you’ll receive an appreciation voucher redeemable at participating restaurants (GrubHub or UberEats delivery) near you!*

* GrubHub and UberEats do not deliver from all participating restaurants.

References:

  1. Natroba Prescribing Information.
  2. Data on file, ParaPRO, LLC.
  3. Seiler, J. C., Keech, R. C., Aker, J. L., Miller, W., Belcher, C., & Mettert, K. W. (2022). SPINOSAD at 0.9% in the treatment of scabies: Efficacy results from 2 multicenter, randomized, double-blind, vehicle-controlled studies. Journal of the American Academy of Dermatology, 86(1), 97–103.

NAT-AWLPSe-000